Concepedia

Samuel M. Levi

SM

Statistics

Publications

11

Citations

1.7K

H-Index

11

Active since

2011

Affiliations

University of Pennsylvania(Current)

Harvard University

Merck & Co., Inc., Rahway, NJ, USA (United States)

The Wistar Institute

The University of Texas MD Anderson Cancer Center

Samuel M. Levi is an author at University of Pennsylvania specializing in pharmacology, life sciences, and autophagy.

ORCID

Publications per year

2011–2022

11

Publications

11

Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma

Xiao-Hong Ma, Sheng-Fu Piao, Souvik Dey et al. · Journal of Clinical Investigation · 2014 · 456 citations · Full text

, , +16

Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency

Quentin McAfee, Zhihui Zhang, Arabinda Samanta et al. · Proceedings of the National Academy of Sciences · 2012 · 415 citations · Full text

, , +17

A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles

Vito W. Rebecca, Michael C. Nicastri, Noel P. McLaughlin et al. · Cancer Discovery · 2017 · 206 citations · Full text

, , +17

Site-selective, stereocontrolled glycosylation of minimally protected sugars

Qiuhan Li, Samuel M. Levi, Corin Wagen et al. · Nature · 2022 · 115 citations · Full text

, , +12

Highly Selective β-Mannosylations and β-Rhamnosylations Catalyzed by Bis-thiourea

Qiuhan Li, Samuel M. Levi, Eric N. Jacobsen · Journal of the American Chemical Society · 2020 · 107 citations · Full text

, , +12

1–5 of 11